JP2007261996A - Acrolein adduct-forming inhibitor, and skin external preparation and food and drink containing the same - Google Patents

Acrolein adduct-forming inhibitor, and skin external preparation and food and drink containing the same Download PDF

Info

Publication number
JP2007261996A
JP2007261996A JP2006089502A JP2006089502A JP2007261996A JP 2007261996 A JP2007261996 A JP 2007261996A JP 2006089502 A JP2006089502 A JP 2006089502A JP 2006089502 A JP2006089502 A JP 2006089502A JP 2007261996 A JP2007261996 A JP 2007261996A
Authority
JP
Japan
Prior art keywords
acrolein
rosaceae
external preparation
aging
fruit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006089502A
Other languages
Japanese (ja)
Other versions
JP5039314B2 (en
Inventor
Kazuhiro Suetsugu
一博 末次
Keiko Tsuji
恵子 辻
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naris Cosmetics Co Ltd
Original Assignee
Naris Cosmetics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naris Cosmetics Co Ltd filed Critical Naris Cosmetics Co Ltd
Priority to JP2006089502A priority Critical patent/JP5039314B2/en
Publication of JP2007261996A publication Critical patent/JP2007261996A/en
Application granted granted Critical
Publication of JP5039314B2 publication Critical patent/JP5039314B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Non-Alcoholic Beverages (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a skin aging care external preparation and an aging care food and drink which contain an acrolein adduct-forming inhibitor by inhibiting the reaction of forming an adduct of the acrolein formed in a living body with a protein, inhibits the formation of wrinkles, flabbiness or the like as to the skin aging care external preparation, and inhibits arteriosclerosis in a living body as to the aging care food and drink. <P>SOLUTION: The acrolein adduct-forming inhibitor comprises at lest one kind of extracts of Passiflora incatnata L. (Passifloraceae), Cornus officinalis (Cornaceae), Euphorbia aggregata (Euphovbiaceae), MAKJONG (Sterculia Lychnophora), Rosa canina (Rosaceae), Chimaphila umbellata L. (Pyrolaceae), Agrimonia pilosa var. japonica (Rosaceae), and Cinnamomum cassia (Lauraceae). <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、アクロレインのアミノ酸やタンパク質との付加体形成阻害剤であり、その付加体形成阻害剤を含有する皮膚抗老化外用剤や抗老化用飲食品に関する。 The present invention relates to an acrolein amino acid or protein adduct formation inhibitor, and relates to a skin anti-aging external preparation or anti-aging food or drink containing the adduct formation inhibitor.

従来より、老化を抑制する抗老化剤としては、種々のものが開発されている。このような生体の老化は、2つの生物学的要因により起こることが知られている Conventionally, various anti-aging agents that suppress aging have been developed. It is known that such biological aging is caused by two biological factors.

1つは生理的老化で、他の1つは紫外線等の暴露部に生じる光老化皮膚と呼ばれるものである。生理的老化は、生体内で生成した活性酸素が影響し、血管や皮膚の主な構成因子であるコラーゲン線維の変性や生理機能に係わりの深い酵素の変質による活性の低下などに関わる。光老化に感しては、紫外線の暴露が原因であるため皮膚に限られる。 One is physiological aging and the other is called photo-aging skin that occurs in exposed areas such as ultraviolet rays. Physiological aging is influenced by active oxygen generated in the living body, and is related to degeneration of collagen fibers, which are the main components of blood vessels and skin, and a decrease in activity due to alteration of enzymes deeply related to physiological functions. Sensation of photoaging is limited to the skin because it is caused by UV exposure.

生理的老化において、活性酸素種を除去することが主に検討され、スーパーオキサイドアニオン、ヒドロキシラジカル、一重項酸素、パーオキシナイトライト等に対する除去剤が提示されている。近年、活性酸素以外の老化因子としてアクロレインの関与が注目されている。 In physiological aging, removal of reactive oxygen species has been mainly studied, and removal agents for superoxide anion, hydroxy radical, singlet oxygen, peroxynitrite and the like have been proposed. In recent years, the involvement of acrolein as an aging factor other than active oxygen has attracted attention.

アクロレインはα,β-不飽和アルデヒドで反応性が高く、タンパク質(酵素やコラーゲン)の変性や細胞毒性に関わり、その細胞毒性は類縁のアルデヒドであるアセトアルデヒド、ホルムアルデヒド、アクロレインを比較するとアクロレインが最も強く、ホルムアルデヒドそしてアセトアルデヒドである。アクロレインの細胞毒性は、活性酸素の要因となりうる過酸化水素に比べても強いことが報告されている(Kenneth Ramos、etal、Toxicology and Applied Pharmacology、Vol.95、61-71 (1988))。 Acrolein is an α, β-unsaturated aldehyde that is highly reactive and is involved in the denaturation and cytotoxicity of proteins (enzymes and collagen). Formaldehyde and acetaldehyde. It has been reported that the cytotoxicity of acrolein is stronger than hydrogen peroxide, which can be a cause of active oxygen (Kenneth Ramos, etal, Toxicology and Applied Pharmacology, Vol. 95, 61-71 (1988)).

アクロレインは、生体内ではポリアミンから生成したり(Gunnar Houen、etal、Acta Chemia Scandinavica、Vol.48、52-60 (1994))、脂質の過酸化反応の過程で生成する(内田浩二、日本油化学会誌、Vol.47、No.11、29-37(1998))ことがわかっている。また、アクロレインはプラスティックの燃焼、たばこ煙、排気ガスや油脂の加熱によって生成される環境汚染物質の一つである。このように、アクロレインの発生過程は、活性酸素の発生過程とよくオーバーラップしており、今まで老化の原因が活性酸素というのが一般的となっているが、実はアクロレインが関与しているのではないのかとも考えられる。また、アクロレインから生体を守る検討では、ポリアミンにポリアミンオキシダーゼが作用しアクロレインを生成することから、ポリアミンオキシダーゼを阻害する特許(特開2002−281999)とリポキシゲナーゼによる酸化過程でアクロレインが生成することからリポキシゲナーゼを阻害する特許(特開2002−138013)が提示されている。しかし、これらによってアクロレインの生成が完全に抑えられるものではない。
特開2002−281999 特開2002−138013 J.Biol.Chem.、Vol.273、No.26、Issue of June26、16058-16066(1998) Kenneth Ramos、etal、Toxicology and Applied Pharmacology、Vol.95、61-71 (1988) Gunnar Houen、etal、Acta Chemia Scandinavica、Vol.48、52-60 (1994) 内田浩二、日本油化学会誌、Vol.47、No.11、29-37(1998)
Acrolein can be produced in vivo from polyamines (Gunnar Houen, etal, Acta Chemia Scandinavica, Vol. 48, 52-60 (1994)) or in the process of lipid peroxidation (Koji Uchida, Nippon Oil Chemicals). (Journal, Vol. 47, No. 11, 29-37 (1998)). Acrolein is one of the environmental pollutants generated by burning plastic, cigarette smoke, exhaust gas and oil. In this way, the generation process of acrolein overlaps well with the process of generation of active oxygen, and until now the cause of aging has generally been active oxygen, but actually acrolein is involved. It may be possible. Further, in the study of protecting a living body from acrolein, since polyamine oxidase acts on polyamine to produce acrolein, a patent (Japanese Patent Laid-Open No. 2002-281999) that inhibits polyamine oxidase and acrolein is produced in the oxidation process by lipoxygenase. A patent (Japanese Patent Application Laid-Open No. 2002-138013) is proposed. However, these do not completely suppress the production of acrolein.
JP 2002-281999 A JP 2002-138013 A J. Biol. Chem., Vol. 273, No. 26, Issue of June 26, 16058-16066 (1998) Kenneth Ramos, etal, Toxicology and Applied Pharmacology, Vol. 95, 61-71 (1988) Gunnar Houen, etal, Acta Chemia Scandinavica, Vol. 48, 52-60 (1994) Koji Uchida, Journal of Japan Oil Chemists' Society, Vol. 47, No. 11, 29-37 (1998)

アクロレインから生体を守る検討では、ポリアミンにポリアミンオキシダーゼが作用しアクロレインを生成することから、ポリアミンオキシダーゼを阻害する特許(特開2002−281999)とリポキシゲナーゼによる酸化過程でアクロレインが生成することからリポキシゲナーゼを阻害する特許(特開2002-138013)が提示されている。しかし、これらによってアクロレインの生成が完全に抑えられるものではなく、生成したアクロレインを直接捕捉する作用を持つ成分が望まれている。 In the study of protecting a living body from acrolein, polyamine oxidase acts on polyamine to produce acrolein, so a patent (JP 2002-281999) that inhibits polyamine oxidase and acrolein is produced in the oxidation process by lipoxygenase inhibits lipoxygenase (Japanese Patent Laid-Open No. 2002-138013) is proposed. However, the production of acrolein is not completely suppressed by these, and a component having an action of directly capturing the produced acrolein is desired.

本発明者等は、このような課題を解決するために鋭意研究を重ねた結果、ポリアミンにポリアミンオキシダーゼが作用することによって生成したり、生体内の脂質の過酸化反応により生じた脂質過酸化生成物であるアクロレインが、生体内のタンパク質との付加体形成を阻害することで本発明を完成するに至った。そして、これらを配合する皮膚外用剤に関しては、皮膚のシワ・タルミなどの皮膚老化を、飲食品に関しては動脈硬化などを改善することが期待できる。 As a result of intensive studies to solve such problems, the present inventors have produced lipid peroxidation produced by the action of polyamine oxidase on polyamine or by peroxidation of lipids in vivo. The acrolein, which is a product, has completed the present invention by inhibiting adduct formation with proteins in the living body. And about the skin external preparation which mix | blends these, it can anticipate improving skin aging, such as skin wrinkles and tarmi, and arteriosclerosis etc. about food-drinks.

本発明におけるアクロレインを直接捕捉する方法は、内田らのアセチルリジンとアクロレインの付加生成物をHPLCで測定する方法(J.Biol.Chem.、Vol.273、No.26、Issue of June26、16058-16066(1998))を改変して行った。 The method of directly capturing acrolein in the present invention is a method of measuring an addition product of acetyllysine and acrolein by Uchida et al. (J. Biol. Chem., Vol. 273, No. 26, Issue of June 26, 16058- 16066 (1998)).

すなわち、0.1Mリン酸緩衝液(pH7.4)に100mMのN-アセチルリジンを溶解し、同様に0.1Mリン酸緩衝液(pH7.4)に10mMのアクロレインを溶解し、それぞれ450μLずつ取り、37℃で24時間反応させる。そこに被検試料を100μL加えて、反応液をHPLCで分析し、アクロレインとN-アセチルリジンの付加生成物を分析し、その生成量から抑制率を算出する。 Specifically, 100 mM N-acetyllysine was dissolved in 0.1 M phosphate buffer (pH 7.4), 10 mM acrolein was dissolved in 0.1 M phosphate buffer (pH 7.4), and 450 μL each was taken. Incubate at 37 ° C for 24 hours. 100 μL of a test sample is added thereto, the reaction solution is analyzed by HPLC, the addition product of acrolein and N-acetyllysine is analyzed, and the inhibition rate is calculated from the amount of the product.

本発明における被検試料は、アクロレインがタンパク質との付加体を生成する過程を抑制するアクロレイン付加体生成抑制剤であり、パッションフラワー(Passiflora incatnata L(Passifloraceae))の全草、サンシュユ(Cornus
officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia
lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物の少なくとも一種を含有させたことを特徴とする。
The test sample in the present invention is an acrolein adduct formation inhibitor that suppresses the process of acrolein forming an adduct with a protein. Passion flower (Passiflora incatnata L (Passifloraceae)) whole plant, Sanshuyu (Cornus
officinalis (Cornaceae)) fruit, dragon fruit (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia)
lychnophora fruit, rose hips (Rosa canina (Rosaceae)), giant scorpion (Chimaphila umbellata L. (Pyrolaceae)), red-eared ground (Agrimonia)
pilosa var. japonica (Rosaceae)) and at least one extract of Cinnamomum cassia (Lauraceae).

また、本発明は、このようなパッションフラワー(Passiflora incatnata L(Passifloraceae))の全草、サンシュユ(Cornus
officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia
lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物の少なくとも一種または二種以上を含有させた皮膚抗老化外用剤および抗老化用飲食品である。
In addition, the present invention provides a whole plant of such passionflower (Passiflora incatnata L (Passifloraceae)), sanshuyu (Cornus
officinalis (Cornaceae)) fruit, dragon fruit (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia)
lychnophora fruit, rose hips (Rosa canina (Rosaceae)), giant scorpion (Chimaphila umbellata L. (Pyrolaceae)), red-eared ground (Agrimonia)
pilosa var. japonica (Rosaceae)), cinnamon flower (Cinnamomum cassia (Lauraceae)) extract containing at least one or two or more skin anti-aging agents and anti-aging foods and drinks.

本発明によれば、パッションフラワー(Passiflora incatnata L(Passifloraceae))の全草、サンシュユ(Cornus
officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia
lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物を含有した安全であり、生体内で生成したアクロレインがタンパク質と付加体を形成する反応を抑えることによるアクロレイン不加体形成抑制剤を含有する皮膚抗老化外用剤および抗老化用飲食品であり、皮膚抗老化外用剤に関してはシワ、タルミ等の発生を抑制することを図り、抗老化用飲食品に関しては生体中の動脈硬化を抑制することが可能となる。
According to the present invention, the whole passionflower (Passiflora incatnata L (Passifloraceae)), sanshuyu (Cornus)
officinalis (Cornaceae)) fruit, dragon fruit (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia)
lychnophora fruit, rose hips (Rosa canina (Rosaceae)), giant scorpion (Chimaphila umbellata L. (Pyrolaceae)), red-eared ground (Agrimonia)
pilosa var. japonica (Rosaceae)) whole plant, cinnamon flower (Cinnamomum cassia (Lauraceae)) extract, safe and acrolein produced in vivo suppresses the reaction to form proteins and adducts It is a skin anti-aging external preparation and anti-aging food / beverage products containing an acrolein non-adduct formation inhibitor. With regard to skin anti-aging external preparations, it is intended to suppress the occurrence of wrinkles, tarmi, etc. Can suppress arteriosclerosis in the living body.

発明実施の最良の形態BEST MODE FOR CARRYING OUT THE INVENTION

本発明に使用する「パッションフラワー」は、薬草として利用されるのは主にincarnata種(チャボトケイソウ)、edulis種(クダモノトケイソウ)の葉、蔓、幹の部分で、主な成分として、多糖体とアルカノイド類を含むフラボノイドに分けられる。研究の結果、このどちらかの成分を単独に使用した場合には鎮静効果は発揮せず、両成分が組み合わさった状態にのみ鎮静効果が確認されたということが報告されている。また、子供に対しても安全に利用できることから、興奮状態の子供を落ち着けるのにも利用されている。 The “passion flower” used in the present invention is mainly used as a medicinal herb in the leaves, vines, and trunks of incarnata species (Chatobodia) and edulis species (Polydiaceae). And flavonoids containing arkanoids. As a result of research, it has been reported that when either of these components is used alone, the sedative effect was not exhibited, and the sedative effect was confirmed only in a state where both components were combined. Moreover, since it can be safely used for children, it is also used to calm excited children.

本発明に使用する「竜珠果」は、Euphorbisは乳液を薬用に用いたと言われている。乳白色の樹液(乳液)は有毒で、刺激性の皮膚炎を起こすことがある。乳液は乳細胞から分泌されるが、乳細胞は乳管という組織を作っている。 As for "Ryuju" used in the present invention, Euphorbis is said to have used an emulsion for medicinal purposes. Milky white sap (milky lotion) is toxic and may cause irritating dermatitis. Milk is secreted from milk cells, which make up a tissue called the duct.

本発明に使用する「MAKJONG」は、Malva nutsとも呼ばれ、東南アジアで果実は食用とされる。コレステロールを抑え、ダイエットなどの作用があるとされる。 “MAKJONG” used in the present invention is also called Malva nuts, and fruits are edible in Southeast Asia. It suppresses cholesterol and is said to have effects such as diet.

本発明に使用する「ローズヒップ」は、ヨーロッパの野ばらの実である。このローズヒップには、レモンの20倍といわれるビタミンCをはじめ、A、B、E、リコピンなども含まれている。 The “rose hip” used in the present invention is a fruit of European wild roses. This rose hip contains vitamin C, which is said to be 20 times that of lemon, as well as A, B, E, and lycopene.

本発明に使用する「オオウメガサソウ」とは、北アメリカのケベック州からジョウジア州とヨーロッパ、日本では茨城県以北の太平洋側、北海道に分布し、アメリカインディアンの間に広く愛用され膀胱結石の薬用に供されている。 "Omegasasou" used in the present invention is distributed from Quebec to North America and Europe in North America, in the Pacific side north of Ibaraki Prefecture in Japan, in Hokkaido, and is widely used by American Indians for medicinal use of bladder stones It is offered to.

本発明に使用する「キンミズヒキ」とは、バラ科ミズヒキ属で、夏に黄花の小花を細長く穂のように咲かせる姿から「金色の水引」に見たてこの名前がついた。全草のエキスは、血小板増加による血液凝固促進と止血作用がありますので、強壮収斂(しゅうれん)止血剤とされていて、喀血(かっけつ)、血便、子宮出血などの止血に用いる。また、抗菌、消炎、鎮痛作用もあり、健胃、下痢止めにも応用される。 The term “Kinzuhiki” used in the present invention is a genus of the family Rosaceae belonging to the family Rosaceae, and is named after “Golden Mizuhiki” in the form of a long and narrow yellow floret that blooms like a spike in summer. Whole herbal extract has a blood coagulation promotion and hemostasis effect due to increased platelets, so it is regarded as a tonic hemostatic agent and used for hemostasis such as hemoptysis, bloody stool, and uterine bleeding. It also has antibacterial, anti-inflammatory and analgesic effects, and can be applied to prevent stomach upset and diarrhea.

本発明に使用する「桂皮花」とは、桂皮で知られるクスノキ科の肉桂の花である。肉桂香辛料や漢方に使用され、薬理作用は鎮静、血圧下降、末梢血管拡張、心臓収縮力増強、ストレス性胃びらん予防効果、胆汁分泌促進、また抗アレルギー、抗炎症、活性酸素産生の抑制などがある。しかし、その花の利用はあまり知られていない。   The “cinnamon flower” used in the present invention is a cinnamon flower of the family Aceraceae known as cinnamon. Used in meat spices and Chinese medicines, pharmacological effects include sedation, blood pressure lowering, peripheral vasodilation, cardiac contraction enhancement, stress gastric erosion prevention effect, promotion of bile secretion, antiallergy, antiinflammation, suppression of active oxygen production, etc. is there. However, the use of that flower is not well known.

即ち、本発明に係る抽出物は、抽出溶媒としては、各種極性有機溶媒及びそれらの混液を用いることができる。抽出物の生成は、様々な方法が用いられるが、各種活性炭、スチレン−ジビニルベンゼン系合成吸着剤(HP−20:三菱化成社製)やオクタデシルシラン処理シリカ(Chromatorex ODS:富士シリシア化学製)により吸着させ、適当な溶媒で溶出する方法が簡便でかつ実用的である。 That is, the extract according to the present invention can use various polar organic solvents and a mixture thereof as the extraction solvent. Various methods are used for the production of the extract. Depending on various activated carbons, styrene-divinylbenzene synthetic adsorbent (HP-20: manufactured by Mitsubishi Kasei Co., Ltd.) and octadecylsilane-treated silica (Chromatorex ODS: manufactured by Fuji Silysia Chemical). The method of adsorbing and eluting with an appropriate solvent is simple and practical.

また、本発明に係る抽出物の各種皮膚外用剤に対する配合量は、皮膚外用剤の実施態様、皮膚外用剤の使用形態等に応じて変動させることができるので特に限定されない。原則的には、有効量存在すれば良いことになるが、一般的には組成物中、乾燥重量に換算して0.0001〜100質量%が利用でき、好ましくは0.01〜10質量%、更に好ましくは0.1〜5.0質量%である。特に、用時調製のパウダー状の製剤等は、この本願発明に係る抽出物が100質量%を含めた高配合率で利用されることが想定できる。 Moreover, since the compounding quantity with respect to the various skin external preparation of the extract which concerns on this invention can be fluctuate | varied according to the embodiment of a skin external preparation, the usage form of a skin external preparation, etc., it is not specifically limited. In principle, an effective amount may be present, but generally 0.0001 to 100% by mass in terms of dry weight can be used in the composition, preferably 0.01 to 10% by mass. More preferably, it is 0.1-5.0 mass%. In particular, it can be assumed that the powdery preparation prepared at the time of use is used at a high blending rate including 100% by mass of the extract according to the present invention.

本発明に係る皮膚外用剤の適用範囲は、特に限定されない。つまり、この発明の有効成分が有する作用効果に応じて各作用効果を利用できる全ての皮膚外用剤に適用できる。 The application range of the external preparation for skin according to the present invention is not particularly limited. That is, the present invention can be applied to all external preparations for skin that can use each function and effect according to the function and effect of the active ingredient of the present invention.

例えば、本発明に係る有効成分を各種皮膚外用剤基剤等に配合して、クリーム、乳液、化粧水、パック剤、洗顔料等に対して適用できる。また、前記各種皮膚外用剤の実施態様は、ローション、エマルジョン、軟膏、ゾル、ゲル、パウダー、スプレー、固形等の各種態様で適用できる。 For example, the active ingredient according to the present invention can be blended in various skin external preparation bases and applied to creams, emulsions, lotions, packs, face wash, and the like. Moreover, the various skin external preparations can be applied in various forms such as lotion, emulsion, ointment, sol, gel, powder, spray, and solid.

また、本発明に係る抗老化用飲食品は、ドリンク剤、ジェル状、粉末製剤、錠剤等の剤型にすることが可能である。 Moreover, the anti-aging food / beverage products according to the present invention can be made into dosage forms such as drinks, gels, powder formulations, tablets and the like.

以下、実施例により本発明を詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention in detail, this invention is not limited to these.

本実施例は、本発明のアクロレインのタンパク質との付加体形成阻害剤について、具体的な抽出例を示したものである。 This example shows a specific extraction example of the adduct formation inhibitor with the acrolein protein of the present invention.

被検体としては、パッションフラワー(Passiflora incatnata L(Passifloraceae))の全草、サンシュユ(Cornus
officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia
lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))を用いた。
The subjects included passionflower (Passiflora incatnata L (Passifloraceae)), Sanshuyu (Cornus)
officinalis (Cornaceae)) fruit, dragon fruit (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia)
lychnophora fruit, rose hips (Rosa canina (Rosaceae)), giant scorpion (Chimaphila umbellata L. (Pyrolaceae)), red-eared ground (Agrimonia)
The whole plant of pilosa var. japonica (Rosaceae)) and cinnamon flowers (Cinnamomum cassia (Lauraceae)) were used.

上記、抽出物の抽出法は、水であれば、60℃で数時間抽出し得ることができる。エタノール抽出であれば、ソックスレー抽出を行うことによって得ることができる。 The extraction method for the extract can be extracted at 60 ° C. for several hours if it is water. If it is ethanol extraction, it can be obtained by performing Soxhlet extraction.

本実施例は、本発明のアクロレインのタンパク質との付加体形成阻害剤について、抑制率を試験したものである。 In this example, the inhibition rate of the acrolein protein adduct formation inhibitor of the present invention was tested.

〔実験例3〕アクロレインとN-アセチルリジンの付加体形成阻害率の測定
(1)実験方法
50mM N-アセチルリジン450μL(50mMPBS(pH7.4))、10mMアクロレイン450μL(50mMPBS(pH7.4))、試料100μLを混合し、37℃で24時間放置後、HPLCで分析を行った。陽性対照として、類似の反応と思われる糖とアミノ酸やタンパク質と起こるメイラード反応の阻害剤としてとして知られるアミノグアニジンを用いて比較を行った。試料濃度は1%の溶液を用いて行った。
[Experimental Example 3] Measurement of adduct formation inhibition rate of acrolein and N-acetyllysine (1) Experimental method
450 μL of 50 mM N-acetyllysine (50 mM PBS (pH 7.4)), 450 μL of 10 mM acrolein (50 mM PBS (pH 7.4)), and 100 μL of the sample were mixed, left at 37 ° C. for 24 hours, and then analyzed by HPLC. As a positive control, a comparison was made using aminoguanidine, which is known as an inhibitor of the Maillard reaction that occurs with sugars and amino acids and proteins that appear to be similar reactions. The sample concentration was 1%.

(2)HPLC条件
カラム:DAISOPAK-SP120
ODS-BP(150mm×6mm)
温度:室温
移動相:5%MeOH in 0.1%TFA
検出:UV227nm
注入量:5μL
流量:1.5mL/min
(2) HPLC condition column: DAISOPAK-SP120
ODS-BP (150mm × 6mm)
Temperature: Room temperature Mobile phase: 5% MeOH in 0.1% TFA
Detection: UV227nm
Injection volume: 5μL
Flow rate: 1.5mL / min

水抽出物のアクロレイン付加体形成阻害作用を表1に、エタノール抽出物のアクロレイン付加体形成阻害作用を表2に示す。 Table 1 shows the acrolein adduct formation inhibitory action of the water extract, and Table 2 shows the acrolein adduct formation inhibitory action of the ethanol extract.

表1の結果より、パッションフラワー(Passiflora
incatnata L(Passifloraceae))の全草、サンシュユ(Cornus officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物にアクロレインとN-アセチルリジンとの付加体の形成を阻害する作用が強いことを確認した。
From the results in Table 1, passion flower (Passiflora
incatnata L (Passifloraceae) whole plant, Sunshuyu (Cornus officinalis (Cornaceae)) fruit, dragon berries (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia lychnophora) fruit, Rosehip (Rosa canina (Rosaceae)), Giant beetle (Chimaphila umbellata L. (Pyrolaceae)), Agrimonia (Agrimonia)
pilosa var. japonica (Rosaceae)) and cinnamon flower (Cinnamomum cassia (Lauraceae)) extracts were confirmed to have a strong inhibitory effect on the formation of adducts of acrolein and N-acetyllysine.

以下に本発明の処方例を挙げる。 The formulation example of this invention is given to the following.

<処方例1>化粧水
(成分名) (質量%)
パッションフラワー水抽出物 0.0001
グリセリン 5.0
ポリオキシエチレンソルビタンモノラウレート(20E.0) 1.5
エタノール 8.0
クエン酸トリエチル 2.0
防腐剤・酸化防止剤 適量
精製水 残部
<Formulation example 1> lotion (component name) (mass%)
Passion flower water extract 0.0001
Glycerin 5.0
Polyoxyethylene sorbitan monolaurate (20E.0) 1.5
Ethanol 8.0
Triethyl citrate 2.0
Preservative / Antioxidant
Purified water balance

<処方例2>化粧用クリーム
(成分名) (質量%)
サンシュユエタノール抽出物 1.0
ミツロウ 2.0
ステアリルアルコール 5.0
ステアリン酸 8.0
スクワラン 10.0
自己乳化型グリセリルモノステアレート 3.0
ポリオキシエチレンセチルエーテル(20E.0) 1.0
グリセリン 5.0
水酸化カリウム 0.3
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Formulation example 2> Cosmetic cream (component name) (mass%)
Sanshuyu ethanol extract 1.0
Beeswax 2.0
Stearyl alcohol 5.0
Stearic acid 8.0
Squalane 10.0
Self-emulsifying glyceryl monostearate 3.0
Polyoxyethylene cetyl ether (20E.0) 1.0
Glycerin 5.0
Potassium hydroxide 0.3
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water

<処方例3>乳液
(成分名) (質量%)
竜珠果水抽出物 5.0
スクワラン 8.0
ワセリン 2.0
ミツロウ 0.5
ソルビタンセスキオレエート 0.8
ポリオキシエチレンオレイルエーテル(20E.0) 1.2
カルボキシビニルポリマー 0.2
グリセリン 1.5
水酸化カリウム 0.1
エタノール 7.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 3> Emulsion (component name) (mass%)
Dragon Juice Extract 5.0
Squalane 8.0
Vaseline 2.0
Beeslow 0.5
Sorbitan sesquioleate 0.8
Polyoxyethylene oleyl ether (20E.0) 1.2
Carboxyvinyl polymer 0.2
Glycerin 1.5
Potassium hydroxide 0.1
Ethanol 7.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water

<処方例4>パック剤
(成分名) (質量%)
ローズヒップ水抽出物 0.001
酢酸ビニル樹脂エマルジョン 15.0
ポリビニルアルコール 10.0
ホホバ油 3.0
グリセリン 5.0
酸化チタン 8.0
カオリン 7.0
エタノール 5.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 4> Packing agent (component name) (mass%)
Rosehip water extract 0.001
Vinyl acetate resin emulsion 15.0
Polyvinyl alcohol 10.0
Jojoba oil 3.0
Glycerin 5.0
Titanium oxide 8.0
Kaolin 7.0
Ethanol 5.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water

<処方例5>軟膏
(成分名) (質量%)
ローズヒップエタノール抽出物 0.01
酢酸トコフェロール 0.5
パラジメチルアミノ安息香酸オクチル 4.0
ブチルメトキシベンゾイルメタン 4.0
ステアリルアルコール 18.0
モクロウ 20.0
グリセリンモノステアリン酸エステル 0.3
ワセリン 33.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 5> Ointment (component name) (mass%)
Rosehip ethanol extract 0.01
Tocopherol acetate 0.5
Octyl paradimethylaminobenzoate 4.0
Butylmethoxybenzoylmethane 4.0
Stearyl alcohol 18.0
Owl 20.0
Glycerin monostearate 0.3
Vaseline 33.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water

<処方例6>ドリンク剤
サンシュユ水抽出物 10.0
クエン酸 0.1
ビタミンC 適量
精製水 残部
<Formulation Example 6> Drink agent sanshuyu water extract 10.0
Citric acid 0.1
Vitamin C appropriate amount purified water balance

<処方例7>粉末製剤
桂皮花水抽出物 80.0
卵殻カルシウム 10.0
乳糖 5.0
セルロース
残部
<Prescription Example 7> Powder preparation Cinnamon flower water extract 80.0
Eggshell calcium 10.0
Lactose 5.0
cellulose
The rest

<処方例8>錠剤
キンミズヒキ水抽出物 10.0
卵殻カルシウム 10.0
乳糖 20.0
澱粉 7.0
デキストリン 8.0
硬化油 5.0
セルロース
残部
<Prescription Example 8> Tablet Kinmizuki Water Extract 10.0
Eggshell calcium 10.0
Lactose 20.0
Starch 7.0
Dextrin 8.0
Hardened oil 5.0
cellulose
The rest

本発明によれば、パッションフラワー(Passiflora
incatnata L(Passifloraceae))の全草、サンシュユ(Cornus officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物を含有した安全であり、生体内で生成したアクロレインがタンパク質と付加体を形成する反応を抑えることによるアクロレイン不加体形成抑制剤を含有する皮膚抗老化外用剤および抗老化用飲食品であり、皮膚抗老化外用剤に関してはシワ、タルミ等の発生を抑制することを図り、抗老化用飲食品に関しては生体中の動脈硬化を抑制することが可能となる。
According to the present invention, passion flower (Passiflora)
incatnata L (Passifloraceae) whole plant, Sunshuyu (Cornus officinalis (Cornaceae)) fruit, dragon berries (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia lychnophora) fruit, Rosehip (Rosa canina (Rosaceae)), Giant beetle (Chimaphila umbellata L. (Pyrolaceae)), Agrimonia (Agrimonia)
pilosa var. japonica (Rosaceae)) whole plant, cinnamon flower (Cinnamomum cassia (Lauraceae)) extract, safe and acrolein produced in vivo suppresses the reaction to form proteins and adducts It is a skin anti-aging external preparation and anti-aging food / beverage products containing an acrolein non-adduct formation inhibitor. With regard to skin anti-aging external preparations, it is intended to suppress the occurrence of wrinkles, tarmi, etc. Can suppress arteriosclerosis in the living body.

アクロレインとN-アセチルリジンの付加体形成阻害率を測定したHPLCチャートHPLC chart measuring the inhibition rate of adduct formation between acrolein and N-acetyllysine

Claims (3)

パッションフラワー(Passiflora
incatnata L(Passifloraceae))の全草、サンシュユ(Cornus officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物の少なくとも一種を含有することを特徴とするアクロレイン付加体形成阻害剤。
Passion flower (Passiflora
incatnata L (Passifloraceae) whole plant, Sunshuyu (Cornus officinalis (Cornaceae)) fruit, dragon berries (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia lychnophora) fruit, Rosehip (Rosa canina (Rosaceae)), Giant beetle (Chimaphila umbellata L. (Pyrolaceae)), Agrimonia (Agrimonia)
An acrolein adduct formation inhibitor characterized by containing at least one extract of pilosa var. japonica (Rosaceae)) and cinnamon flowers (Cinnamomum cassia (Lauraceae)).
請求項1記載のアクロレイン付加体形成阻害剤の少なくとも1種又は2種以上を有効成分として含有することを特徴とする皮膚抗老化外用剤。 A topical anti-aging agent for skin containing at least one or more of the acrolein adduct formation inhibitor according to claim 1 as an active ingredient. 請求項1記載のアクロレイン付加体形成阻害剤の少なくとも1種又は2種以上を有効成分として含有することを特徴とする抗老化用飲食品。 An anti-aging food or drink comprising at least one or more of the acrolein adduct formation inhibitor according to claim 1 as an active ingredient.
JP2006089502A 2006-03-28 2006-03-28 Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same Active JP5039314B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006089502A JP5039314B2 (en) 2006-03-28 2006-03-28 Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006089502A JP5039314B2 (en) 2006-03-28 2006-03-28 Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same

Publications (2)

Publication Number Publication Date
JP2007261996A true JP2007261996A (en) 2007-10-11
JP5039314B2 JP5039314B2 (en) 2012-10-03

Family

ID=38635341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006089502A Active JP5039314B2 (en) 2006-03-28 2006-03-28 Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same

Country Status (1)

Country Link
JP (1) JP5039314B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010029973A1 (en) * 2008-09-12 2010-03-18 丸善製薬株式会社 Skin-whitening agent, anti-aging agent, and skin cosmetic
JP2010143862A (en) * 2008-12-19 2010-07-01 Sunstar Inc Composition containing plant extract
EP2269621A4 (en) * 2008-03-31 2012-02-22 Shiseido Co Ltd Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents
WO2012050162A1 (en) * 2010-10-15 2012-04-19 株式会社資生堂 Cellular life span extending agent, and telomerase activator
JP2013213015A (en) * 2012-04-04 2013-10-17 Morishita Jintan Co Ltd Tie2 activating agent

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10226617A (en) * 1997-02-18 1998-08-25 Kao Corp Skin preparation for external use
JP2002138013A (en) * 2000-10-27 2002-05-14 Pias Arise Kk Hne-and-acrolein formation inhibiting and hne-and- acrolein decomposition promoting agent, and skin aging care preparation for external use
JP2002332224A (en) * 2001-03-06 2002-11-22 Kose Corp Anti-ageing skin care preparation and anti-ageing skin care preparation composition
JP2003034631A (en) * 2001-07-17 2003-02-07 Koei Kogyo Kk Fibroblast proliferation-promoting agent and aging- preventing cosmetics
JP2003048812A (en) * 2001-07-31 2003-02-21 Koei Kogyo Kk Elastase inhibitor and antiaging cosmetic
JP2003201214A (en) * 2001-10-23 2003-07-18 Shiseido Co Ltd Matrix metalloprotease activity inhibitor
JP2004067590A (en) * 2002-08-06 2004-03-04 Naris Cosmetics Co Ltd Female sex hormone production promoter and skin preparation for external use containing the same
JP2004149729A (en) * 2002-10-31 2004-05-27 Ikeda Shokken Kk Antioxidant
JP2004189663A (en) * 2002-12-11 2004-07-08 Ichimaru Pharcos Co Ltd Maillard reaction inhibitor
JP2005008539A (en) * 2003-06-17 2005-01-13 Fancl Corp Matrix metalloproteinase inhibitor
JP2005029556A (en) * 2002-10-31 2005-02-03 Ikeda Shokken Kk Skin aging-preventing agent
JP2006160630A (en) * 2004-12-03 2006-06-22 Naris Cosmetics Co Ltd Acrolein adduct formation inhibitor, external preparation for skin containing the same, and healthy supplement food
JP2006273810A (en) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd Inhibitor against acrolein adduct formation, external preparation for skin and health supplement containing the same
JP2007517883A (en) * 2004-01-07 2007-07-05 イーエルシー マネージメント エルエルシー Cosmetic composition containing protein and enzyme inhibitors

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10226617A (en) * 1997-02-18 1998-08-25 Kao Corp Skin preparation for external use
JP2002138013A (en) * 2000-10-27 2002-05-14 Pias Arise Kk Hne-and-acrolein formation inhibiting and hne-and- acrolein decomposition promoting agent, and skin aging care preparation for external use
JP2002332224A (en) * 2001-03-06 2002-11-22 Kose Corp Anti-ageing skin care preparation and anti-ageing skin care preparation composition
JP2003034631A (en) * 2001-07-17 2003-02-07 Koei Kogyo Kk Fibroblast proliferation-promoting agent and aging- preventing cosmetics
JP2003048812A (en) * 2001-07-31 2003-02-21 Koei Kogyo Kk Elastase inhibitor and antiaging cosmetic
JP2003201214A (en) * 2001-10-23 2003-07-18 Shiseido Co Ltd Matrix metalloprotease activity inhibitor
JP2004067590A (en) * 2002-08-06 2004-03-04 Naris Cosmetics Co Ltd Female sex hormone production promoter and skin preparation for external use containing the same
JP2004149729A (en) * 2002-10-31 2004-05-27 Ikeda Shokken Kk Antioxidant
JP2005029556A (en) * 2002-10-31 2005-02-03 Ikeda Shokken Kk Skin aging-preventing agent
JP2004189663A (en) * 2002-12-11 2004-07-08 Ichimaru Pharcos Co Ltd Maillard reaction inhibitor
JP2005008539A (en) * 2003-06-17 2005-01-13 Fancl Corp Matrix metalloproteinase inhibitor
JP2007517883A (en) * 2004-01-07 2007-07-05 イーエルシー マネージメント エルエルシー Cosmetic composition containing protein and enzyme inhibitors
JP2006160630A (en) * 2004-12-03 2006-06-22 Naris Cosmetics Co Ltd Acrolein adduct formation inhibitor, external preparation for skin containing the same, and healthy supplement food
JP2006273810A (en) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd Inhibitor against acrolein adduct formation, external preparation for skin and health supplement containing the same

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2269621A4 (en) * 2008-03-31 2012-02-22 Shiseido Co Ltd Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents
US9320770B2 (en) 2008-03-31 2016-04-26 Shiseido Company, Ltd. Blood vessel maturation, normalization or stabilization agent and wrinkle preventer/improver
WO2010029973A1 (en) * 2008-09-12 2010-03-18 丸善製薬株式会社 Skin-whitening agent, anti-aging agent, and skin cosmetic
JP2010065009A (en) * 2008-09-12 2010-03-25 Maruzen Pharmaceut Co Ltd Skin brightener and anti-aging agent, and skin cosmetic
JP2010143862A (en) * 2008-12-19 2010-07-01 Sunstar Inc Composition containing plant extract
WO2012050162A1 (en) * 2010-10-15 2012-04-19 株式会社資生堂 Cellular life span extending agent, and telomerase activator
JP2013213015A (en) * 2012-04-04 2013-10-17 Morishita Jintan Co Ltd Tie2 activating agent

Also Published As

Publication number Publication date
JP5039314B2 (en) 2012-10-03

Similar Documents

Publication Publication Date Title
JP4033877B2 (en) Composition for promoting type I collagen production
KR101760959B1 (en) Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical compositions comprising same
KR101713357B1 (en) Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra
KR20210095741A (en) Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same
WO2021104276A1 (en) Uses of fu tea extract in preparing skin-conditioning product
JP7338105B2 (en) Kapok tree flower extract and cosmetic, pharmaceutical or dermatological composition containing the same
JP5063947B2 (en) Acrolein adduct formation inhibitor, and skin anti-aging external preparation and anti-aging food and drink containing the same
JP5039314B2 (en) Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same
JP2006111545A (en) Glutathione reductase activity-enhancing agent
JP5773111B2 (en) Composition for inhibiting skin pigmentation and use thereof
JP2004067590A (en) Female sex hormone production promoter and skin preparation for external use containing the same
JPH10120583A (en) Antiallergic agent, chemical mediator liberation suppressant and antiallergic cosmetic, medicine and food comprising the sam
KR101744889B1 (en) Composition for Anti-oxidation, Whitening and Wrinkles protection
JP2008024601A (en) Inhibitor for acrolein adduct formation, skin anti-aging external preparation and anti-aging food and beverage containing the same
JP4866012B2 (en) Acrolein adduct formation inhibitor, skin external preparation and health supplement containing the same
JP6055667B2 (en) Collagen production promoter
US10143648B2 (en) Peptide and oside extract of schisandra fruit and improvement in the response of the cutaneous neurosensory system
JP4944372B2 (en) Acrolein adduct formation inhibitor, and skin external preparation and health supplement containing the same
KR101914441B1 (en) Cosmetic compositions for improving skin moisturizing comprising fucosterol
KR101904501B1 (en) Cosmetic compositions for improving skin wrinkles or skin elasticity comprising fucosterol
JP5777209B2 (en) Collagen production promoter and food composition
KR101797526B1 (en) Hair cosmetic composition containing an extract of Dendropanax morbifera ferment
JP4247091B2 (en) Skin anti-aging agent
JP2011195530A (en) Protein glycation inhibitor
JP4169814B2 (en) A topical skin preparation containing agave or sisal extract

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090327

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120123

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120420

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120612

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120709

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150713

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5039314

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250